Cargando…

The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review

A major obstacle for treatment of HCC is the inadequate efficacy and limitation of the available therapeutic options. Despite the recent advances in developing novel treatment options, HCC still remains one of the major causes of cancer morbidity and mortality around the world. Achieving effective t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juengpanich, Sarun, Shi, Liang, Iranmanesh, Yasaman, Chen, Jiang, Cheng, Zhenzhe, Khoo, Aaron Kah-Jin, Pan, Long, Wang, Yifan, Cai, Xiujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558093/ https://www.ncbi.nlm.nih.gov/pubmed/31176993 http://dx.doi.org/10.1016/j.tranon.2019.04.021

Ejemplares similares

Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
por: Pan, Long, et al.
Publicado: (2019)

Risk factors and consequences of conversion in minimally invasive distal pancreatectomy
por: Jiang, Zhiyu, et al.
Publicado: (2022)

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
por: Pan, Long, et al.
Publicado: (2020)

Laparoscopic procedure is associated with lower morbidity for simultaneous resection of colorectal cancer and liver metastases: an updated meta-analysis
por: Pan, Long, et al.
Publicado: (2020)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Development of synthetic lethality in cancer: molecular and cellular classification
por: Li, Shijie, et al.
Publicado: (2020)

Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning
por: Chen, Mingyu, et al.
Publicado: (2020)

Targeting mutant p53 for cancer therapy: direct and indirect strategies
por: Hu, Jiahao, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
por: Chen, Mingyu, et al.
Publicado: (2021)

Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer
por: Cao, Jiasheng, et al.
Publicado: (2021)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
por: Topatana, Win, et al.
Publicado: (2020)

Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma
por: Eresen, Aydin, et al.
Publicado: (2021)

Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
por: Sung, Pil Soo, et al.
Publicado: (2018)

Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
por: Hu, Jiahao, et al.
Publicado: (2022)

Role of estrogen in hepatocellular carcinoma: is inflammation the key?
por: Shi, Liang, et al.
Publicado: (2014)

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
por: Xia, Shunjie, et al.
Publicado: (2020)

Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma
por: Zhang, Qiang-Bo, et al.
Publicado: (2013)

Natural killer cells inhibit pulmonary metastasis of hepatocellular carcinoma in nude mice
por: HONG, ZAI-FA, et al.
Publicado: (2016)

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020)

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021)

Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
por: Huang, Juanjuan, et al.
Publicado: (2023)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
por: Liu, Pingyi, et al.
Publicado: (2018)

A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma
por: Xi, Deyang, et al.
Publicado: (2023)

Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis
por: Tong, Yifan, et al.
Publicado: (2017)

Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma
por: Jiang, Guangyi, et al.
Publicado: (2020)

Laparoscopic surgery for early gallbladder carcinoma: A systematic review and meta-analysis
por: Feng, Xu, et al.
Publicado: (2020)

Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor
por: Cheung, Phyllis FY, et al.
Publicado: (2015)

Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
por: Zhuang, Lihui, et al.
Publicado: (2018)

The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
por: Hassona, Mona M, et al.
Publicado: (2021)

Therapeutic efficacy of dendritic cell injection in advanced hepatocellular carcinoma: the role of natural killer and T lymphocytes
por: Zaghloul, Amr, et al.
Publicado: (2022)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Natural Food for Sarcopenia: A Narrative Review
por: Nazri, Nurul Syahidah Mohd, et al.
Publicado: (2022)

Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Xiao, Yong-Sheng, et al.
Publicado: (2013)

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients
por: Bray, Sarah M., et al.
Publicado: (2011)

Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells
por: Kim, Miok, et al.
Publicado: (2018)

Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2018)

Immunotherapy of Hepatocellular Carcinoma with Magnetic PD-1 Peptide-Imprinted Polymer Nanocomposite and Natural Killer Cells
por: Lee, Mei-Hwa, et al.
Publicado: (2019)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2023)

MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma
por: Yan, Jianing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mcoge725ej0qtj2a3i2a01pdng